Sartorius stock draws fresh targets before October 22 results

Published on 10/03/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius stock faces two fresh target changes before the October 22 report, with Barclays at EUR 310 and Goldman Sachs at EUR 244. The shares were last at EUR 251.40 on October 2, 2026.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern — Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius stock (ISIN DE0007165631) was last at EUR 251.40 on Xetra on October 2, 2026, at 5:35 p.m. CEST, up 0.16 percent from the prior close. The immediate catalyst is a cluster of analyst updates before the company reports third-quarter results on October 22, 2026.

Barclays lifts its target

According to FinanzNachrichten.de on September 30, 2026, Barclays raised its Sartorius price target from EUR 300 to EUR 310 and retained an Overweight rating. The new target is EUR 58.60 above the Xetra price, equivalent to 23.3 percent above EUR 251.40.

Barclays analyst Charles Pitman-King expects Sartorius to narrow its 2026 outlook toward the middle of the existing corridor ahead of the third-quarter report. That makes the October 22 update important because the market is looking for greater precision rather than a wholly new strategy.

Goldman stays more cautious

FinanzNachrichten.de reported on October 1, 2026, that Goldman Sachs lifted its target from EUR 228 to EUR 244 while keeping a Neutral rating. Analyst James Quigley placed his third-quarter adjusted EBITDA view slightly above consensus, citing a steady recovery in bioprocessing.

The split in targets is material. Barclays sees EUR 310, while Goldman Sachs uses EUR 244, leaving a EUR 66 gap between two current views and highlighting the sensitivity of the valuation to the speed of the bioprocessing recovery.

October 22 becomes the checkpoint

According to FinanzNachrichten.de on September 28, 2026, JPMorgan kept an Overweight rating and a EUR 295 target, expecting Sartorius to exceed third-quarter expectations slightly. The bank also identified the October 22 reports as the next test for market expectations.

Sartorius lists fiscal 2026 sales growth guidance of 5 to 9 percent in constant currencies and expects its underlying EBITDA margin to rise above 30 percent. Its 2025 sales were EUR 3.5 billion, up 7.6 percent in constant currencies, giving the upcoming report a clear comparison base.

Stock remains below its yearly high

Sartorius preference shares were last at EUR 251.40 on Xetra on October 2, 2026, with a session range of EUR 247.00 to EUR 254.30. The EUR 251.40 price stood 6.89 percent below the 52-week high of EUR 270.00 and 26.69 percent above the 52-week low of EUR 198.50. Market capitalization was EUR 17.4 billion and volume was 103,967 shares on the same session.